SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001144204-18-007659
Filing Date
2018-02-13
Accepted
2018-02-13 12:31:29
Documents
1
Group Members
FORESITE CAPITAL FUND IV, L.P.FORESITE CAPITAL MANAGEMENT II, LLCFORESITE CAPITAL MANAGEMENT IV, LLCJAMES TANANBAUM

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tv485578_sc13ga.htm SC 13G/A 87196
  Complete submission text file 0001144204-18-007659.txt   88899
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Subject) CIK: 0001590560 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A | Act: 34 | File No.: 005-88012 | Film No.: 18601296
SIC: 2834 Pharmaceutical Preparations

Mailing Address 600 MONTGOMERY STREET SUITE 4500 SAN FRANCISCO CA 94111
Business Address 600 MONTGOMERY STREET SUITE 4500 SAN FRANCISCO CA 94111 415-877-4887
Foresite Capital Fund II, L.P. (Filed by) CIK: 0001594914 (see all company filings)

IRS No.: 901029166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A